Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Long-term safety of gantenerumab in participants with Alzheimer's disease: A phase III, open-label extension study (SCarlet RoAD).
J Alzheimers Dis. 2024 Dec 16:13872877241303644. doi: 10.1177/13872877241303644. Online ahead of print.
J Alzheimers Dis. 2024.
PMID: 39686620
Long-Term Safety of Gantenerumab in Participants with Alzheimer's Disease: A Phase III, Double-Blind, and Open-Label Extension Study (Marguerite RoAD).
Neve A, Das B, Wojtowicz J, Huang Z, Bullain S, Watkin M, Lott D, Bittner T, Delmar P, Klein G, Hofmann C, Kerchner GA, Smith J, Baudler M, Fontoura P, Doody RS.
Neve A, et al. Among authors: watkin m.
J Alzheimers Dis. 2024;101(1):353-367. doi: 10.3233/JAD-240221.
J Alzheimers Dis. 2024.
PMID: 39177596
Free PMC article.
Clinical Trial.
Item in Clipboard
What Next After MBSR/MBCT? An Open Trial of an 8-Week Follow-on Program Exploring Mindfulness of Feeling Tone (vedanā).
Williams JMG, Baer R, Batchelor M, Crane RS, Cullen C, De Wilde K, Fennell MJV, Kantor L, Kirby J, Ma SH, Medlicott E, Gerber B, Johnson M, Ong EL, Peacock JW, Penman D, Phee A, Radley L, Watkin M, Taylor L.
Williams JMG, et al. Among authors: watkin m.
Mindfulness (N Y). 2022;13(8):1931-1944. doi: 10.1007/s12671-022-01929-0. Epub 2022 Jul 7.
Mindfulness (N Y). 2022.
PMID: 35818377
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.